Key facts
- This page summarizes Richard J. Rodgers's Form 4 filing for Sagimet Biosciences Inc. (SGMT).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 20 Jul 2023, 16:18.
Richard J. Rodgers - 18 Jul 2023 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)
- Reporting relationship
- Director
- Issuer ticker
- SGMT
- Reported as of
- 18 Jul 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Jul 2023, 16:18:46 UTC
- Prior SEC filing
- 13 Jul 2023
- Next SEC filing
- 31 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dennis Hom, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard J. Rodgers filed Form 4 for Sagimet Biosciences Inc. (SGMT) on 20 Jul 2023.
Change
- Previous filing in this sequence was filed on 13 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -1,976
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,976
- Exercise price
- $23.05
- Footnotes
- F1, F2
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,976
- Change %
- Price
- $0.000000
- Shares after
- 1,976
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Series A Common Stock
- Underlying amount
- 1,976
- Exercise price
- $23.05
- Footnotes
- F1, F2
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -23,216
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,216
- Exercise price
- $6.36
- Footnotes
- F1, F2
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +23,216
- Change %
- Price
- $0.000000
- Shares after
- 23,216
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Series A Common Stock
- Underlying amount
- 23,216
- Exercise price
- $6.36
- Footnotes
- F1, F2
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -23,839
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,839
- Exercise price
- $6.36
- Footnotes
- F1, F2
SGMT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +23,839
- Change %
- Price
- $0.000000
- Shares after
- 23,839
- Date
- 18 Jul 2023
- Ownership
- Direct
- Underlying class
- Series A Common Stock
- Underlying amount
- 23,839
- Exercise price
- $6.36
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.
Footnote F2
The shares underlying this option are fully vested and exercisable as of the date hereof.